Dewis a'r dinesydd? Penderfyniadau iechyd a'u goblygiadau ar gyfer datblygu dinasyddiaeth Gymreig


Dewis a'r dinesydd? Penderfyniadau iechyd a'u goblygiadau ar gyfer datblygu dinasyddiaeth Gymreig
Myfanwy Davies

Mae lle arbennig i wasanaethau iechyd fel gofod i ddiffinio perthynas priodol y dinesydd â’r wladwriaeth fodern. Bu disgwyliad i unigolion ddewis ym maes iechyd yng Nghymru a Lloegr ers yr 1980au. Yn ddiweddar cyflwynwyd brechlyn newydd i ferched sy’n amddiffyn yn erbyn rhai mathau o gancr ceg y groth. Disgwylir i rieni gydsynio dros eu merched. Mae’r papur hwn yn adrodd canlyniadau’r astudiaeth ymchwil ansoddol fwyaf yn y byd ar y pwnc . Mae’n darlunio agweddau at ddewisiadau iechyd a thrafod profiadau rhieni wrth ddod i benderfynu i gydsynio ai peidio. Dadansoddir strategaethau rhieni wrth benderfynu, er eu hansicrwydd.


Cyfeiriad:

 
  	Myfanwy Davies, 'Dewis a'r dinesydd? Penderfyniadau iechyd a'u goblygiadau ar gyfer datblygu dinasyddiaeth Gymreig', Gwerddon, 10/11, Awst 2012, 40-63.
   

Allweddeiriau

 
    Dewis, defnyddioldeb, dinasyddiaeth, GIG, cancr.
    

Llyfryddiaeth:

 
  	
  1. Allen, J., et al. (2010), ‘Parental decision making about the HPV vaccine’, Cancer Epidemiol Biomarkers Prev., 19 (9), 2172-86.
  2. Allsop, J., a Baggott, R. (2004), ‘The NHS in England: From modernisation to marketisation?’, Soc. Policy Rev., 16, 29-44.
  3. Brabin, L., Roberts, S., a Kitchener, H. (2007), ‘A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent’, BMC Public Health, 7 (2) doi: 10.1186/1471-2458-7-20.
  4. Brewer, N. a Fazekas, K. (2007), ‘Predictors of HPV vaccine acceptability: A theoryinformed systematic review’, Preventive Medicine, 45, 107-14.
  5. Black, L., et al. (2009), ‘Literature review of human papillomavirus vaccine acceptability among women over 26 years’, Vaccine, 27 (11), 1668-73.
  6. Calnan, M., a Gabe, J. (2001), ‘From consumerism to partnership? Britain’s National Health Service at the turn of the century’, International Journal of Health Services, 31 (1), tt. 119-131.
  7. Charles, C., Gafni, A., a Whelan,T. (1997), ‘Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango)’, Social Science & Medicine, 44 (5), 681-92.
  8. Charmaz, K. (2006), Constructing Grounded Theory: A practical Guide Through Qualitative Analysis (London: Sage).
  9. Cooper Robbins, S., et al. (2010), ‘ “I just signed”: Factors influencing decision-making for school-based HPV vaccination of adolescent girls’, Health Psychology, 29 (6), 618-25.
  10. Department of Health (1989), Working for patients, Cm 555 (London: HMSO).
  11. Department of Health (1991), The Patient’s Charter (London: HMSO).
  12. Department of Health (2000), The NHS Plan: A Plan for Investment, A Plan for Reform (London: HMSO).
  13. Department of Health (2003), Building on the Best: Choice, Responsiveness and Equity in the NHS (London: HMSO).
  14. Department of Health (2004), The NHS Improvement Plan: Putting People at the Heart of the Public Services (London: HMSO).
  15. Department of Health (2010), Equity and Excellence: Liberating the NHS (London: The Stationary Office).
  16. Elwyn, G., a Miron-Shatz, T. (2009), ‘Deliberation before determination: the definition and evaluation of good decision making’, Health Expectations, 13, 139-47.
  17. Epstein, R.M., a Street, R.L. (2011), ‘Shared Mind: Communication, Decision Making, and Autonomy in Serious Illness’, Annals of Family Medicine, 9 (5), 454-61.
  18. Farrington-Douglas, J., ac Allen, J. (2005), Equitable Choices for Health (London: Institute for Public Policy Research).
  19. Forster, R., a Gabe, J. (2008), ‘Voice or choice? Patient and public involvement in the National Health Service in England under New Labour’, International Journal of Health Services, 38, 333-56.
  20. Foucault, M., ‘Governmentality’, yn M. Foucault (1997), The Essential Works 1954-1984, Vol. III: Power. J. Faubion (gol.), (New York: The New Press), tt. 201-22.
  21. Fox, S. (2011), The Social Life of Health Information (Washington, USA: Pew Research Center’s Internet & American Life Project).
  22. Greener, I. (2009), Healthcare in the UK (Bristol: Policy Press).
  23. Guillaume, L., a Bath, P. (2004), ‘The impact of health scares on parents’ information needs and preferred information sources: a case study of the MMR vaccine scare’, Health Informatics Journal, 10 (1), 5-22.
  24. Henderson, L., et al. (2011), ‘ “A false sense of security?” Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age’, Journal of Medical Screening, 18 (1), 41-5.
  25. Her Majesty’s Governemt (1969), The Family Law Reform Act 1969 (London: HMSO).
  26. Hobsbawm, E. (1994), Age of Extremes: the Short Twentieth Century, 1914-1991 (London: Michael Joseph, 1994).
  27. Hunter, D. J. (2009), ‘The case against choice and competition’, Health Economics, Policy and Law, 4, 489-501.
  28. Joint Committee on Vaccination and Immunisation, Minutes of the HPV Sub-Group Meeting: Wednesday 28th February 2007.
  29. Kendall, L. (2001), The Future Patient (London: Institute for Public Policy Research).
  30. Litton, A., et al. (2011), ‘Factors Associated with Intention to Vaccinate a Daughter against HPV: A Statewide Survey in Alabama’, Journal of Pediatric and Adolescent Gynecology, 24 (3), 166-71.
  31. Lupton, D. (1999), Risk (London: Routledge).
  32. Llywodraeth Cynulliad Cymru (2005), Designed for Life: A Ten Year Plan for the NHS in Wales (Caerdydd: Llywodraeth Cynulliad Cymru).
  33. Marquand, D. (1997), The New Reckoning: Capitalism, States and Citizens (Cambridge: Polity Press).
  34. Marshall, T.H. (1950), Citizenship and Social Class and other Essays (Cambridge: Cambridge University Press).
  35. Marteau, T.M., Dormandy, E., a Michie, S. (2001). ‘A measure of informed choice’, Health Expectations, 4, 98-108.
  36. eto, J., et al. (2004), ‘Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort’, British Journal of Cancer, 91 (5), 942-53.
  37. Petts, J., a Niemeyer, S. (2004), ‘Health risk communication and amplification: learning from the MMR vaccination controversy’, Health Risks and Society, 6 (1), 7-23.
  38. Public Health Wales (2010), Vaccine Uptake in Children in Wales, COVER Annual Report 2010 (Pontypool: National Public Health Service for Wales).
  39. Rachet, B., et al. (2009), ‘Population-based cancer survival trends in England and Wales up to 2007: An assessment of the NHS cancer plan for England’, The Lancet Oncology, 10 (4), 351-69.
  40. Raithatha, N., et al. (2003), ‘A qualitative investigation of vaccine risk perception amongst parents who immunize their children: a matter of public health concern’, Journal of Public Health Medicine, 25 (2), 161-4.
  41. Rose, N. (1996), Inventing Our Selves (Cambridge: Cambridge University Press).
  42. Rose, N. (1999), Governing the Soul: The Shaping of the Private Self (London: Free Association Books).
  43. Sanders, G., a Taira, A. (2003), ‘Cost Effectiveness of a Potential Vaccine for Human papillomavirus’, Emerging Infectious Diseases, 9 (1), 37-48.
  44. Savage, R., ac Armstrong, D. (1990), ‘Effect of a general practitioner’s consulting style on patients’ satisfaction: A controlled study’, British Medical Journal, 301 (6758), 968-70.
  45. Sepucha, K., et al. (2007), ‘An Approach to measuring the quality of breast cancer decisions’, Patient Education and Counselling, 65, 261-9.
  46. Shack, L., Jordan, C., Thomson, C. S., Mak, V., Møller, H. (2008), ‘Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England’, BMC Cancer, 8, 271.
  47. Smith, T., a Babbington, E. (2006), ‘Devolution: A Map of Divergence in the NHS’, Health Policy Review, 1 (2), 9-40.
  48. Sporton, R., a Francis, S.A. (2001), ‘Choosing not to immunize: Are parents making informed decisions?’, Family Practice, 18 (2), 181-8.
  49. Stretch, R., et al. (2008), ‘Parental attitudes and information needs in an adolescent HPV vaccination programme’, British Journal of Cancer, 99 (11), 1908-11.
  50. Sontag, S. (1978), Illness as Metaphor (New York: Farrar Straus Giroux).
  51. Taira, A., Neukermans, C., a Sanders, G. (2004), ‘Evaluating human papillomavirus vaccination programs’, Emerging Infectious Diseases, 10 (11), 1915-23.
  52. Waller, J., Marlow, L. a Wardle, J. (2006), ‘Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: A qualitative study’, Cancer Epidemiology Biomarkers and Prevention, 15, 1257-61.